| 1. |
- Kehoe, Laura, et al.
(författare)
-
Make EU trade with Brazil sustainable
- 2019
-
Ingår i: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 364:6438, s. 341-
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
| 2. |
- Ignatowicz, Monika, 1983-, et al.
(författare)
-
ISO-PARAFFINS AS LOW TEMPERATURE SECONDARY FLUIDS
- 2017
-
Ingår i: 5TH IIR INTERNATIONAL CONFERENCE ON THERMOPHYSICAL PROPERTIES AND TRANSFER PROCESSES OF REFRIGERANTS (TPTPR). - : INT INST REFRIGERATION. ; , s. 436-442
-
Konferensbidrag (refereegranskat)abstract
- Ethylene and propylene glycol water based secondary solutions are very popular due to their low corrosivity character, low freezing point, high boiling point and low fire hazards. The main drawback of ethylene glycol solutions is its potential toxicity both to the environment, animals and food products. Therefore, propylene glycol is the most common substitute for ethylene glycol. The biggest disadvantage of propylene glycol solutions is its very high viscosity at low temperatures, which results in higher pumping power and lower system performance. For very low temperatures, it is common to use non-aqueous synthetic fluids, which have lower viscosities at these temperatures. Thus, the aim of this paper is to propose a new generation of synthetic iso-paraffins having better thermophysical properties compared to existing synthetic products used for very low temperature applications. The first results showed that the new generation of iso-paraffins having the freezing temperature of - 50 degrees C or lower had significantly lower viscosity (between 75 % and 98 %) at very low temperatures compared to 60 wt-% propylene glycol (PG 60 %) and 60 wt-% ethylene glycol solution (EG 60 %). Iso-paraffin 1 showed better performance than iso-paraffin 2 by giving the lowest freezing point, the lowest dynamic viscosity and kinematic viscosity as well as the highest thermal conductivity. Instead, iso-paraffin 2 had higher specific heat capacity. As seen, the different composition of iso-paraffin mixture can result in different properties and operating temperature ranges. Thus, iso-paraffins could become an interesting alternative for very low temperature cooling applications.
|
|
| 3. |
- Grönwall, Caroline, et al.
(författare)
-
Generation of Affibody (R) ligands binding interieukin-2 receptor alpha/CD25
- 2008
-
Ingår i: Biotechnology and applied biochemistry. - 0885-4513 .- 1470-8744. ; 50:2, s. 97-112
-
Tidskriftsartikel (refereegranskat)abstract
- Affibody (R) molecules specific for human IL-2R alpha, the IL-2 (interieukin-2) receptor a subunit, also known as CD25, were selected by phage-display technology from a combinatorial protein library based on the 58-residue Protein A-derived Z domain. The IL-2R system plays a major role in T-cell activation and the regulation of cellular immune responses. Moreover, CD25 has been found to be overexpressed in organ rejections, a number of autoimmune diseases and T-cell malignancies. The phage-display selection using Fc-fused target protein generated 16 unique Affibody (R) molecules targeting CD25. The two most promising binders were characterized in more detail using biosensor analysis and demonstrated strong and selective binding to CD25. Kinetic biosensor analysis revealed that the two monomeric Affibody (R) molecules bound to CD25 with apparent affinities of 130 and 240 nM respectively. The Affibody (R) molecules were, on biosensor analysis, found to compete for the same binding site as the natural ligand IL-2 and the IL-2 blocking monoclonal antibody 2A3. Hence the Affibody (R) molecules were assumed to have an overlapping binding site with IL-2 and antibodies targeting the IL-2 blocking Tac epitope (for example, the monoclonal antibodies Daclizumab and Basiliximab, both of which have been approved for therapeutic use). Furthermore, immunofluorescence microscopy and flow-cytometric analysis of CD25-expressing cells demonstrated that the selected Affibody (R) molecules bound to CD4(+) CD25(+) PMBCs (peripheral-blood mononuclear cells), the IL-2-dependent cell line NK92 and phytohaemagglutinin-activated PMBCs. The potential use of the CD25-binding Affibody (R) molecules as targeting agents for medical imaging and for therapeutic applications is discussed.
|
|
